Novartis to begin ADHD study in girls.
In: PharmaWatch: CNS, Jg. 2 (2003-10-01), Heft 10, S. 12-12
report
Zugriff:
Reports on the commencement of a new clinical study to evaluate the efficacy and safety of Ritalin LA extended release capsules in girls aged 12 to 17 years old with attention-deficit/hyperactivity disorder (ADHD). Study design; Objective of the study; Potential impact of the study in the management of ADHD in girls.
Titel: |
Novartis to begin ADHD study in girls.
|
---|---|
Zeitschrift: | PharmaWatch: CNS, Jg. 2 (2003-10-01), Heft 10, S. 12-12 |
Veröffentlichung: | 2003 |
Medientyp: | report |
Schlagwort: |
|
Sonstiges: |
|